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Background: Current ESC guidelines highlight the possible influence of bleeding complications on outcome of ACS. Little is known about the 
prevalence of major bleeding complications in STEMI in clinical practice.
Methods: Between Oct 2006 to Oct 2008, 21,582 consecutive patients with ACS were enrolled into the ACS-Registry of the Euro Heart Survey 
Programme to document treatment and hospital complications. We examined the impact of major bleeding complications (bleeding with drop in 
haemoglobin >5g/dl or haematocrit > 15%) on hospital outcome of STEMI in Europe.
Results: Of 8,732 patients with STEMI, 281 (3.2%) had major bleeding complications. Patients with major bleedings were older, more often female 
and more often received PCI as well as treatment with GP IIb/IIIa blockers than patients without bleeding complications. Predominant location of 
bleeding was puncture site for the coronary intervention (52.6%). Hospital mortality was significantly higher in patients with major bleeding even 
after correction for differences in baseline-characteristics and treatment (OR 2.18, 95% CI 1.45-3.29).
Conclusion: Major bleeding complications in patients with STEMI in clinical practice in more than 50% were bleedings at the puncture site for the 
coronary intervention. Major bleeding independently was associated with doubled hospital mortality. 
Major bleeding
n=281
No major bleed
n=8451
p-value
Age [years] 69 64 < 0.01
Female Gender 36.7 % 15.0 % <0.01
Prior MI 14.3 % 29.6 % ns
Prior PCI 8.5 % 8.3 % ns
Prior Bypass 1.4 % 2.1 % ns
Prior Stroke 6.1 % 5.2 % ns
Diabetes mellitus 23.7 % 21.9 % ns
Renal Failure 4.7 % 4.1 % ns
Fibrinolysis 23.8 % 24.5 % ns
Primary / Rescue PCI 82.2 % 65.8 % <0.01
GP IIb/IIIa 46.2 % 31.7 % <0.01
ASA 96.8 % 95.6 % ns
Clopidogrel 87.2 % 86.4 % ns
LMW-Heparin 45.0 % 41.9 % ns
Unfr. Heparin 76.1 % 75.6 % ns
Hospital Mortality 14.2 % 7.1 % <0.01
